Sponsor:
Brigham and Women's Hospital
Code:
NCT07315997
Conditions
Rheumatoid Arthritis (RA
Atherosclerotic Cardiovascular Disease (ASCVD)
Eligibility Criteria
Sex: All
Age: 35 - 70+
Healthy Volunteers: Not accepted
Interventions
high sensitivity cardiac troponin
Brief summary:
Conditions
Rheumatoid Arthritis (RA
Atherosclerotic Cardiovascular Disease (ASCVD)
Study ID
NCT07315997
Start date
Sep 4, 2024
Status verified date
Dec, 2025
Completion date
Mar 4, 2028
Anticipated
Primary completion date
Mar 4, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 35 - 70+
Healthy Volunteers: Not accepted
Enrollment
120 participants
Anticipated
Interventions
high sensitivity cardiac troponin
Primary outcome measure
Locations
Massachusetts General Hospital: Rheumatology
Recruiting
Boston, Massachusetts, United States, 02114
Contacts
Principal Investigator:
Sheila Arvikar, MD
Brigham and Womens Hospital
Recruiting
Boston, Massachusetts, United States, 02115
Contacts
Principal Investigator:
Katherine P Liao, MD, MPH
Brigham and Women's Faulkner Hospital
Recruiting
Boston, Massachusetts, United States, 02130
Contacts
Principal Investigator:
Nicole Yang, MD
Sponsor
Brigham and Women's Hospital
Last update posted
Jul 14, 2026
Last verified
Dec, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Brigham and Women's Hospital on 2026-07-14.